PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,000 | +155.6% | 9,482 | +169.5% | 0.00% | – |
| Q1 2020 | $9,000 | 0.0% | 3,518 | +17.4% | 0.00% | – |
| Q2 2019 | $9,000 | -40.0% | 2,997 | -29.0% | 0.00% | – |
| Q1 2019 | $15,000 | -68.8% | 4,221 | -79.5% | 0.00% | – |
| Q2 2018 | $48,000 | +242.9% | 20,607 | +279.9% | 0.00% | -100.0% |
| Q4 2017 | $14,000 | -84.8% | 5,424 | -80.1% | 0.00% | -75.0% |
| Q3 2017 | $92,000 | +24.3% | 27,254 | +23.1% | 0.00% | -20.0% |
| Q3 2016 | $74,000 | -18.7% | 22,131 | -24.3% | 0.01% | -16.7% |
| Q2 2016 | $91,000 | +550.0% | 29,241 | +938.4% | 0.01% | +500.0% |
| Q3 2015 | $14,000 | -89.1% | 2,816 | -84.7% | 0.00% | -93.3% |
| Q1 2015 | $129,000 | – | 18,357 | +37363.3% | 0.02% | – |
| Q4 2014 | $0 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |